Acute lymphoblastic leukemia (ALL) Treatment in Turkey
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Acute lymphoblastic leukaemia (ALL)?
Acute Lymphoblastic Leukemia (ALL) is a malignancy involving the blood and bone marrow and is characterised by the abnormal growth of immature white blood cells (lymphoblasts). The incidence peaks in children, and adults may also be diagnosed with it.
What is the Importance of Timely Treatment?
- Improved Survival Rates: The sooner the diagnosis of ALL is made and treatment begins, the stronger the possibility that it will result in remission and long-term survival.
- Prevention of Complications: It results in serious complications, such as infection, bleeding, or disturbance in organ function. Prompt treatment thus reduces the chance of such life-threatening conditions, brings disease control, and develops the immune response.
- Better Response to Treatment: The earlier the intervention for acute lymphoblastic leukaemia, the more probable it is for the patient to respond favourably to chemotherapy, stem cell transplantation, or other therapeutic regimes.
- Reduced risk of Relapse: Timely and aggressive treatment should ensure complete remission, reducing the chance of relapse. Earlier detection makes all of them easier to treat, with relapse prevention being critical for long-term outcomes.
- Quality of life: The patient is expected to suffer fewer side effects and enjoy an increased quality of life during and after treatment due to early diagnosis and treatment.
What are the Common Symptoms of Acute Lymphoblastic Leukemia (ALL)?
- Fatigue and Weakness
- Pale Skin
- Frequent Infections or Fever
- Easy Bruising or Bleeding
- Swollen Lymph Nodes
- Bone or Joint Pain
- Loss of Appetite or Unexplained Weight Loss
- Shortness of Breath or Dizziness
- Abdominal Pain or Fullness
Causes and Risk Factors of Acute Lymphoblastic Leukemia (ALL)
Causes
- Genetic Mutations
- Chromosomal Abnormalities
- Infections
- Immune System Disorders
- Exposure to Radiation or Chemicals
Risk Factors
- Age
- Family History
- Previous Cancer Treatment
- Environmental Exposures
- Genetic Syndromes
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Acute Lymphoblastic Leukemia (ALL) in Turkey
The current focus of ALL treatment advancements is targeted therapy and immunotherapy. Research on CAR-T therapy has shown promising results in modifying the patient's immune cells to attack leukemia cells. Monoclonal antibodies like blinatumomab and inotuzumab ozogamicin precisely target the malignant cells, and next-generation sequencing (NGS) identifies genetic mutations for personalised treatment. MRI evaluation significantly helps in treatment modification and, ultimately, outcome. Bone marrow transplant using haploidentical donors shall most definitely expand the donor pool. Novel chemotherapeutic protocols and reduced intensity conditioning have given increments to survival, at least for some high-risk patients.
Acute lymphoblastic leukemia (ALL) Prevention Tip:
- Radiation avoidance exposure: Minimize exposure from medical imaging radiation; high doses are associated with risk for ALL. They should be used to radiate only those individuals who are medically indicated.
- Protection from Harmful Chemicals: Long-term or repetitive exposure to chemicals such as benzene (mostly from industrial sources and some household products) and pesticides can be injurious and related to incidences of leukemia.
- Healthy Lifestyle Choices: Healthy living practices such as keeping a healthy lifestyle with a balanced diet, exercising, and habitually avoiding tobacco smoking may still boost overall health and the immune system to prevent some cancers.
- Regular Medical Check-ups: Early detection matters. A regular check-up can identify unusual symptoms early so that if someone develops leukaemia, he or she will have a higher chance of successful treatment.
- Genetic Counseling: A genetic counsellor might inform people about future risks and early follow-ups to find loopholes, whereas such information is shared with people with existing leukaemia or heritable conditions such as Down syndrome.
Treatment options for Acute lymphoblastic leukemia (ALL)
The medical treatment for Acute lymphoblastic leukaemia (ALL) requires evaluating the patient's severity and medical condition. The following are the treatment options:
Chemotherapy : Chemotherapy for ALL always comes first: induction chemotherapy for remission, consolidation and maintenance chemotherapy to prevent relapse and maintain the remission.
Cost Start From USD 7420 - USD 30000Explore Options
Targeted Therapy : Tyrosine Kinase Inhibitors (TKIs), such as Imatinib, are used in Philadelphia chromosome-positive ALL, along with monoclonal antibodies, which target leukaemia cells and stimulate the immune response.
Cost Start From USD 7500 - USD 12000Explore Options
Stem Cell Transplantation : Allogeneic transplants from matched donors or autologous (using the patient's cells) are an option for high-risk or relapsed cases to restore normal blood cell production.
Cost Start From USD 15000 - USD 25000Explore Options
Immunotherapy : CAR-T cell therapy, a promising approach for patients with relapsed ALL, involves engineering the patient's T-cells to target and kill leukaemia cells. Immune checkpoint inhibitors are being explored to augment immune response against leukaemia.
Cost Start From USD 7420 - USD 42500Explore Options
Radiation Therapy and Supportive Care: CNS-directed radiation is indicated for leukaemias that go into the brain, while supportive care measures such as blood transfusions and prevention of infections can help ameliorate side effects and improve the patient's outcome during treatment.
CAR-T Cell Therapy : It emerges as a revolutionised therapy for patients with Acute Lymphoblastic Leukemia (ALL), particularly for patients with minimal responses to conventional treatment.
Cost Start From USD 25000 - USD 55000Explore Options
These are the standard diagnostic methods for diagnosing Acute lymphoblastic leukaemia (ALL):
Imaging Studies
- Chest X-rays or CT scans are utilised for the assessment of enlarged lymph nodes, spleen, liver, or other organ manifestations with potentially proven blood dissemination of leukaemia.
- Ultrasound: It evaluates organ enlargement, especially in the liver or spleen, which are commonly affected by leukaemia.
Blood Tests
- Complete Blood Count (CBC): CBC abnormalities can be seen in the levels of white blood cells, red blood cells, and platelets of a person having leukaemia. It manifests common signs of low blood counts, especially anaemia and thrombocytopenia.
- Peripheral Blood Smear: Under a microscope, a smear is made by spreading blood on a slide to check for immature white blood cells, known as blast cells, which are typical of ALL.
Bone Marrow Biopsy
- A core needle biopsy from the hip bone to take a marrow sample for the presence of leukaemia cells. Blood cells are manufactured in the bone marrow, with leukemic cells displacing the healthy population and forming blood.
Lumbar Puncture (Cerebrospinal Fluid Analysis)
- Lumbar punctures (spinal taps) are done to see if leukaemia has spread into the central nervous system (CNS). During such an operation, a portion of cerebrospinal fluid (CSF) is extracted from the region surrounding the spinal cord and the brain to search for signs of leukaemia cells.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
- Rehabilitation: The purpose of physical therapy in the recovery process is to regain mobility and strength after chemotherapy or a stem cell transplant.
- Occupational Therapy: Occupational therapy assists patients in reclaiming familiar daily living skills such as dressing and cooking. It also gives skills in overcoming those cognitive challenges brought about by chemotherapy or radiation, thus improving mental function.
- Psychological Support: There is a need for emotional support, learning therapy, and support groups for patients suffering from the stress involved in all treatments.
- Lifestyle Modification: Counseling from a dietitian will involve the creation of individualised meal plans to cope with symptoms such as loss of appetite, nausea, and other treatment effects.
- Pain Relief: Pain relief programs such as medication, acupuncture, and massage therapy are designed to ease the patient's discomfort resulting from treatment.
Instantly Connect with our Specialists
Hospitals for Acute lymphoblastic leukemia (ALL) in Turkey
Medicana Camlica Hospital
Istanbul, Turkey
Medicana Camlica Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- 150 bedded Hospital
- Specialty-based clinics
- Fully-equipped patient rooms
Hisar Intercontinental Hospital
Istanbul, Turkey
Architecture of the Hospital designed as per the comfort of patients-
- Consisting of 8 floors, 212 bed capacity
- 75m2 suite rooms
- 35 thousand m2 closed area
- 7 operating rooms
- 53 polyclinics
- 54 Departments
- Hotel-like patient rooms
- Intensive care units consisting of 33 beds
- Hyperbaric Oxygen Center inside the hospital
- PYXIS computerized medicine system working with fingerprint
- Social waiting areas
- Indoor and Outdoor Cafeterias & Restaurants
Acibadem Kadikoy Hospital
Istanbul, Turkey
Acibadem Kadikoy Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- The number of beds in the hospital are 138 and Intensive Care beds are 23.
- There are as many as 6.500 access points for a building control system.
- There are 10 Operating theatres and more than 500 employees.
- There are specific healthcare facilities in Acibadem Kadikoy Hospital, Istanbul, Turkey which have been established per integrated healthcare outreach such as Breast Health Center, Check-up Center, and Diabetes Clinic etc.
- The hospital has the very best of Medical Technologies such as Flast CT, da Vinci robot, Magnetom Area MRI, Greenlight, Ortophos XG 3D and Full Body MRI, 4-Dimensional Breast Ultrasound, 3-Dimensional Tomosynthesis Digital Mammography.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Turkey for Acute Lymphoblastic Leukemia Treatment?
The following are the growing reasons for Turkey being frequented for Pancreatic Neuroendocrine Tumor treatment:
- World-Class Health Services at Affordable Costs: The nation is proficient in advanced medical technologies and treatments, including high-quality care at often dissimilar cost ratios of Western countries.
- Qualified Professionals: Patients will find internationally trained, renowned hepatologists, surgeons, and specialists. Medical and individualised treatment options will complement the value of the care provided by the best experts in Turkey.
- Complete Medical Services: From advanced diagnostic tools such as elastography and imaging to liver transplants, Turkey has gone the extra mile to provide patients with cutting-edge facilities for total Acute lymphoblastic leukaemia (ALL) treatment.
- Medical Travel: Turkey is becoming a central international hub for medical tourism. Many accredited hospitals provide excellent service to international patients, including easy accessibility, visa assistance, and organised packages.
- Holistic Treatment: Most hospitals in Turkey work towards a mainstream plus traditional treatment regime for complete liver health recovery and wellness, thus attending to emotional and physical wellness.
Frequently Asked Questions
Survival rates are likely to vary according to the age and subtype of the disease at diagnosis and the response to treatment. Children diagnosed with ALL have no 5-year survival rates of about 85% to 90%. Adults have lower rates, but this figure is improving with treatment.
Yes, relapse is likely, especially for high-risk cases. Management of relapse may include aggressive chemotherapy, stem cell transplant, or CAR-T cell therapy.
Cancer treatment can be accompanied by side effects, which could include fatigue alongside nausea due to the shedding of hair, further summing it all into the incidence of infections and, sometimes, anaemia. These could be followed by adverse consequences wherein development could have taken place before birth, for instance, those possible with children or perhaps concerns with fertility among adults.
Stem cell transplants (either autologous or allogeneic) are for high-risk or relapsed ALL patients, as they restore healthy blood cells after the patient undergoes intensive therapy through chemotherapy or radiation.
Most cases are not hereditary; however, some genetic conditions such as Down syndrome or Li-Fraumeni syndrome may add to the likelihood of developing ALL. A family history of leukaemia may increase the risk in moderate amounts.
Yes, CAR-T cell therapy for either relapsed or refractory ALL is available in some specialised centers.
Reputed hospitals have dedicated pediatric oncology units for treating children with ALL.
There are excellent transplant centers in Turkey that offer matched and haploidentical transplants.
Depending on the staging and whichever protocol is employed, it could vary anywhere from a few months to a few years.
Yes, hospitals provide long-term post-treatment follow-ups for monitoring remission and relapse.